You are here: Home » News-IANS » Health-Medicine
Business Standard

Inactive ingredients in medicines may cause allergy

Topics
Health Medical Pharma

IANS  |  New York 

Be cautious while taking medicines as a new study suggests that some ingredients added to pills to improve their shelf life may cause allergy or lead to adverse reactions.

The study found that more than 90 per cent of all oral medications tested contained at least one ingredient including lactose, peanut oil, gluten and chemical dyes that can cause gastrointestinal issues and difficulty in breathing in sensitive individuals.

These components are added to improve the taste, shelf life, absorption and other characteristics of a pill, said researchers from the Massachusetts Institute of Technology (MIT) in the US.

"There are hundreds of different versions of pills or capsules that deliver the same medication using a different combination of inactive ingredients," said Daniel Reker from the varsity.

For the study, published in the journal Science Translational Medicine, the team analysed data on inactive ingredients in over 42,000 oral medications that contained more than 350,000 inactive ingredients.

The findings showed a total of 38 inactive ingredients that cause allergic symptoms after oral exposure. Approximately 45 per cent of medications contained lactose, nearly 33 per cent contained a food dye, and 0.08 per cent contained peanut oil.

For certain drugs, such as progesterone, there are few alternatives that do not contain this inactive ingredient.

"While we call these ingredients 'inactive', in many cases they are not. While the doses may be low, we don't know what the threshold is for individuals to react in the majority of instances," the researchers noted.

Precision care and the role for regulation and legislation are essential when it comes to labelling medications that contain an ingredient that may cause an adverse reaction, the team suggested.

--IANS

pb/vc/mag/bg

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Sat, March 16 2019. 16:46 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU